Clinical application of trans-arterial radioembolization in hepatic malignancies in Europe: first results from the prospective multicentre observational study CIRSE …
T Helmberger, R Golfieri, M Pech, T Pfammatter… - Cardiovascular and …, 2021 - Springer
Purpose To address the lack of prospective data on the real-life clinical application of trans-
arterial radioembolization (TARE) in Europe, the Cardiovascular and Interventional …
arterial radioembolization (TARE) in Europe, the Cardiovascular and Interventional …
Yttrium-90 Activity Quantification in PET/CT–Guided Biopsy Specimens from Colorectal Hepatic Metastases Immediately after Transarterial Radioembolization Using …
N Naydenov, A Teplov, MZ Zirakchian, S Ruan… - Journal of Vascular and …, 2023 - Elsevier
Purpose To evaluate the yttrium-90 (90 Y) activity distribution in biopsy tissue samples of the
treated liver to quantify the dose with higher spatial resolution than positron emission …
treated liver to quantify the dose with higher spatial resolution than positron emission …
[HTML][HTML] Y 玻璃微球用于胰腺癌治疗时的器官剂量计算
王江霞， 王薇， 汪传高， 郭金森， 庞洪超 - 中国辐射卫生, 2024 - html.rhhz.net
目的通过建立个体体素模型, 模拟计算胰腺癌治疗中90 Y 玻璃微球给药后对胰腺及周围敏感
器官的吸收剂量, 为90 Y 玻璃微球应用于胰腺癌治疗的临床应用提供技术支撑. 方法在Geant4 …
器官的吸收剂量, 为90 Y 玻璃微球应用于胰腺癌治疗的临床应用提供技术支撑. 方法在Geant4 …
[PDF][PDF] El uso de microesferas de vidrio marcadas con Itrio-90 en el tratamiento del hepatocarcinoma
PO Sasot, D Pérez-Enguix, P Bello-Arques… - 2022 - roderic.uv.es
OBJETIVO: Establecer el valor pronóstico de las variables incluidas en el estudio (clínicas,
analíticas y demográficas) en la progresión de enfermedad y la supervivencia global de …
analíticas y demográficas) en la progresión de enfermedad y la supervivencia global de …